Mylan Laboratories
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease (NCT00002110) | Mylan Laboratories |
Track Mylan Laboratories automatically
Every clearance here is in the API, with alerts when new ones post.